R/R Multiple Myeloma: Review of the CARTITUDE Trial

December 23, 2020
Targeted Oncology

Recent updates from the ASH 2020 annual meeting on the phase 1b/2 CARTITUDE-1 trial for relapsed/refractory multiple myeloma.